Joseph Stallone, OD Optometrist Medicare: Medicare Enrolled Practice Location: 205 Main St, Norwalk, CT 06851 Phone: 203-845-2020 |
Martin D. Arkin, P.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 148 East Ave, Norwalk, CT 06851 Phone: 203-866-3280 Fax: 203-866-1124 |
Complete Eyecare, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 650 Main Ave, Norwalk, CT 06851 Phone: 203-321-9597 |
Dr. Jamee Patel, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 205 Main St, Norwalk, CT 06851 Phone: 203-845-2020 Fax: 203-845-2085 |
Danielle Jaclyn Feder, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 5 Eversley Ave, Norwalk, CT 06851 Phone: 203-853-1010 |
Vision World Optometrist Medicare: Not Enrolled in Medicare Practice Location: 650 Main Ave, Norwalk, CT 06851 Phone: 203-846-3400 Fax: 203-229-0535 |
Dr. David Jason Folman, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 148 East Ave Ste 3c, Norwalk, CT 06851 Phone: 203-866-3280 Fax: 203-866-1124 |
Sadia Rabael Bhatti, OD Optometrist Medicare: Medicare Enrolled Practice Location: 100 N Water St Ste 2825, Norwalk, CT 06854 Phone: 203-523-7204 |
Dr. Randy Leigh Schulman, O.D. Optometrist - Vision Therapy Medicare: May Accept Medicare Assignments Practice Location: 139 Main St, Norwalk, CT 06851 Phone: 203-840-1991 |
Dr. Anita Bharat Arwade Singh, OD Optometrist Medicare: Medicare Enrolled Practice Location: 111 East Ave Ste 335, Norwalk, CT 06851 Phone: 203-853-2020 Fax: 203-852-9553 |
Michelle Kulowski Posey, OD Optometrist Medicare: Medicare Enrolled Practice Location: 100 N Water St Ste 2825, Norwalk, CT 06854 Phone: 203-523-7204 Fax: 203-523-7299 |
Connecticut Glaucoma Associates Optometrist Medicare: Not Enrolled in Medicare Practice Location: 111 East Ave, Suite 335, Norwalk, CT 06851 Phone: 203-853-2020 Fax: 203-852-9553 |
Norwalk Eye Care Llc Optometrist Medicare: Medicare Enrolled Practice Location: 5 Eversley Ave, Suite 104, Norwalk, CT 06851 Phone: 203-853-1010 Fax: 203-866-0767 |
Mark S. Feder, O.d. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5 Eversley Ave, Suite 104, Norwalk, CT 06851 Phone: 203-853-1010 Fax: 203-866-0767 |
Dr. Mary Beth Schanz, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 488 Main Ave Ste 2, Norwalk, CT 06851 Phone: 203-853-9000 Fax: 203-853-1359 |
Harvey Mortimer Tuckman, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 8 Duck Pond Road, Norwalk, CT 06855 Phone: 203-838-1877 Fax: 203-838-1877 |
Patrice Marra, OD Optometrist Medicare: Medicare Enrolled Practice Location: 350 Connecticut Ave, Norwalk, CT 06854 Phone: 203-866-0788 Fax: 203-852-1915 |
Danielle Goldberg, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 5 Eversley Ave, Norwalk, CT 06851 Phone: 203-853-1010 |
National Vision Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 500 Connecticut Ave Ste 6, Norwalk, CT 06854 Phone: 203-523-7229 |
Pearle Vision Optometrist Medicare: Not Enrolled in Medicare Practice Location: 350 Connecticut Ave, Norwalk, CT 06854 Phone: 203-866-0788 Fax: 203-852-1915 |
News Archive
In 2000, the measles virus was declared eliminated from the United States. Despite cases coming in from outside the country, there were few outbreaks because most people were vaccinated against measles. And then 2019 happened.
Idera Pharmaceuticals today announced that it had completed patient enrollment in its randomized, double-blind, placebo-controlled Phase 2 trial of IMO-3100 in patients with moderate-to-severe plaque psoriasis. IMO-3100 is an antagonist of specific Toll-like Receptors (TLRs) that the Company is developing for the treatment of psoriasis and other autoimmune diseases.
Prostate cancer is the second prevent type of cancer that exists. Prostate cancer is usually a slowly progressing disease but it can sometimes manifest as an aggressive cancer. Prostate imaging is the primary way to diagnose the disease and this necessity drives its demand in the clinic.
Eye injections of the drug Avastin, used to treat retinal diseases, bring no greater risk of endophthalmitis, a potentially blinding eye infection, than injections with the much more expensive drug Lucentis made by the same company, according to new research from the Perelman School of Medicine at the University of Pennsylvania. Their findings are published today in JAMA Ophthalmology.
Discovery Laboratories, Inc. today announced that the Office of Orphan Products Development of the United States Food and Drug Administration (FDA) has granted orphan drug designation to Discovery's KL4 surfactant for the treatment of cystic fibrosis (CF).
› Verified 1 days ago